In terms of prediction Oaknin et al. could point out that expression of PD-L1 alone is not reliably predictive but could contribute together with TMB to better indicate responsiveness of ICi treatment in patients with advanced pretreated endometrial cancer [14]. This evidence concerns the gene CD274 and endometrial cancer.